IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 3, Issue 4 (2022)
J Clinic Care Skill 2022, 3(4): 167-170 |
Back to browse issues page
Article Type:
History
Received: 2022/11/7 | Accepted: 2022/12/28 | Published: 2022/12/10
Received: 2022/11/7 | Accepted: 2022/12/28 | Published: 2022/12/10
How to cite this article
Nikooe S, Ghasemi H, Zarei M R, Vakilpour H, Alipoor B. Association between the ACE I/D Variant and COVID-19 Susceptibility and Severity; a Meta-Analysis. J Clinic Care Skill 2022; 3 (4) :167-170
URL: http://jccs.yums.ac.ir/article-1-160-en.html
URL: http://jccs.yums.ac.ir/article-1-160-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran
2- Department of Basic Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
3- Department of Laboratory Sciences, Faculty of Paramedicine, Yasuj University of Medical Sciences, Yasuj, Iran
4- Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
5- Department of Laboratory Sciences, Faculty of Paramedicine, Yasuj University of Medical Sciences, Yasuj, Iran ,behnaalipoor@gmail.com
2- Department of Basic Sciences, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
3- Department of Laboratory Sciences, Faculty of Paramedicine, Yasuj University of Medical Sciences, Yasuj, Iran
4- Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
5- Department of Laboratory Sciences, Faculty of Paramedicine, Yasuj University of Medical Sciences, Yasuj, Iran ,
Abstract (1866 Views)
Aims: Several studies investigated the association of ACE I/D polymorphism with the risk and severity of COVID-19 infection. However, the information in each of the published studies is limited, and the results were inconsistent or even contradictory. Accordingly, this meta-analysis evaluated the association between ACE I/D polymorphism and COVID-19 susceptibility and severity.
Materials & Methods: Two investigators independently searched the PubMed, Embase, Google Scholar, Scopus, and Science Direct databases. Five studies including 1029 cases and 3561 controls were retrieved to evaluate the association between ACE I/D polymorphism and the risk of COVID-19. Furthermore, a meta-analysis of the correlation between the ACE I/D variant and the severity of infection covered 5 case-control studies, including 264 sever-cases and 447 mild cases.
Findings: There was no association between the ACE I/D variant in all genetic models and COVID-19 susceptibility. However, our analysis revealed that there was a significant association between ACE I/D variant in the allele contrast (95% CI=0.5291-0.8353; p<0.001), recessive (95% CI=0.4268-0.9172; p=0.01) and dominant (95% CI=0.3974-0.8092; p=0.001) models and severity of COVID-19.
Conclusion: ACE I/D polymorphism is associated with the severity of COVID-19 infection. There is no association between the ACE I/D variant in all genetic models and COVID-19 susceptibility.
Materials & Methods: Two investigators independently searched the PubMed, Embase, Google Scholar, Scopus, and Science Direct databases. Five studies including 1029 cases and 3561 controls were retrieved to evaluate the association between ACE I/D polymorphism and the risk of COVID-19. Furthermore, a meta-analysis of the correlation between the ACE I/D variant and the severity of infection covered 5 case-control studies, including 264 sever-cases and 447 mild cases.
Findings: There was no association between the ACE I/D variant in all genetic models and COVID-19 susceptibility. However, our analysis revealed that there was a significant association between ACE I/D variant in the allele contrast (95% CI=0.5291-0.8353; p<0.001), recessive (95% CI=0.4268-0.9172; p=0.01) and dominant (95% CI=0.3974-0.8092; p=0.001) models and severity of COVID-19.
Conclusion: ACE I/D polymorphism is associated with the severity of COVID-19 infection. There is no association between the ACE I/D variant in all genetic models and COVID-19 susceptibility.
Keywords:
References
1. Zhang N, Wang L, Deng X, Liang R, Su M, He C, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92(4):408-17. [DOI:10.1002/jmv.25674] [PMID] [PMCID]
2. Huang P, Wang H, Cao Z, Jin H, Chi H, Zhao J, et al. A rapid and specific assay for the detection of MERS-CoV. Front Microbiol. 2018;9:1101. [DOI:10.3389/fmicb.2018.01101] [PMID] [PMCID]
3. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523-34. [DOI:10.1038/nrmicro.2016.81] [PMID] [PMCID]
4. Jiang S, Xia S, Ying T, Lu L. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell mol Immunol. 2020;17(5):554-. [DOI:10.1038/s41423-020-0372-4] [PMID] [PMCID]
5. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. [DOI:10.1038/s41586-020-2012-7] [PMID] [PMCID]
6. Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG, et al. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020;56(1):2000912. [DOI:10.1183/13993003.00912-2020] [PMID] [PMCID]
7. Lu J, Sun PD. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity. J Biol Chem. 2020;295(52):18579-88. [DOI:10.1074/jbc.RA120.015303] [PMID] [PMCID]
8. Zheng H, Cao JJ. Angiotensin-converting enzyme gene polymorphism and severe lung injury in patients with Coronavirus disease 2019. Am J Pathol. 2020;190(10):2013-7. [DOI:10.1016/j.ajpath.2020.07.009] [PMID] [PMCID]
9. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166(5):646-50. [DOI:10.1164/rccm.2108086] [PMID]
10. Aladag E, Tas Z, Ozdemir BS, Akbaba TH, Akpınar MG, Goker H, et al. Human Ace D/I polymorphism could affect the clinicobiological course of COVID-19. J Renin Angiotensin Aldosterone Syst. 2021;2021:5509280. [DOI:10.1155/2021/5509280] [PMID] [PMCID]
11. Kouhpayeh HR, Tabasi F, Dehvari M, Naderi M, Bahari G, Khalili T, et al. Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: A preliminary case-control study. Transl Med Commun. 2021;6(1):26. [DOI:10.1186/s41231-021-00106-0] [PMID] [PMCID]
12. Verma S, Abbas M, Verma S, Khan FH, Raza ST, Siddiqi Z, et al. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Infect Genet Evol. 2021;91:104801. [DOI:10.1016/j.meegid.2021.104801] [PMID] [PMCID]
13. Hubacek JA, Dusek L, Majek O, Adamek V, Cervinkova T, Dlouha D, et al. ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors. Clin Chim Acta. 2021;519:206-9. [DOI:10.1016/j.cca.2021.04.024] [PMID] [PMCID]
14. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. [DOI:10.1371/journal.pmed.1000097] [PMID] [PMCID]
15. Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, Carmona-Saez P. MetaGenyo: A web tool for meta-analysis of genetic association studies. BMC Bioinformatics. 2017;18(1):563. [DOI:10.1186/s12859-017-1990-4] [PMID] [PMCID]
16. Vahedi A, Tabasi F, Monjazebi F, Hashemian SMR, Tabarsi P, Farzanegan B, et al. Clinical Features and Outcomes of ICU Patients with COVID-19 Infection in Tehran, Iran: a Single-Centered Retrospective Cohort Study. Tanaffos. 2020;19(4):300-11. [link]
17. McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LA, McAllister DA, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: A cohort study of the total population of Scotland. The Lancet. 2021;9(2):82-93. [link]
18. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-6. [DOI:10.1038/nature03712] [PMID] [PMCID]
19. Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583(7818):830-3. [DOI:10.1038/s41586-020-2312-y] [PMID]
20. Bader M. ACE2, angiotensin-(1-7), and Mas: The other side of the coin. Pflugers Arch. 2013;465(1):79-85. [DOI:10.1007/s00424-012-1120-0] [PMID]
21. Tikellis C, Thomas M. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294. [DOI:10.1155/2012/256294] [PMID] [PMCID]
22. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74. [DOI:10.1007/s11427-020-1643-8] [PMID] [PMCID]
23. Gómez J, Albaiceta GM, García-Clemente M, López-Larrea C, Amado-Rodríguez L, Lopez-Alonso I, et al. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020;762:145102. [DOI:10.1016/j.gene.2020.145102] [PMID] [PMCID]
24. Calabrese C, Annunziata A, Coppola A, Pafundi PC, Guarino S, Di Spirito V, et al. ACE gene I/D polymorphism and acute pulmonary embolism in Covid 19 pneumonia: a potential predisposing role. Front Med (Lausanne). 2020;7:631148. [DOI:10.3389/fmed.2020.631148] [PMID] [PMCID]
25. Matsuda A, Kishi T, Jacob A, Aziz M, Wang P. Association between insertion/deletion polymorphism in angiotensin-converting enzyme gene and acute lung injury/acute respiratory distress syndrome: A meta-analysis. BMC Med Genetics. 2012;13(1):1-8. [DOI:10.1186/1471-2350-13-76] [PMID] [PMCID]
26. Pabalan N, Tharabenjasin P, Suntornsaratoon P, Jarjanazi H, Muanprasat C. Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis. Infect Genet Evol. 2021;88:104682. [DOI:10.1016/j.meegid.2020.104682] [PMID] [PMCID]
27. Hu Z, Jin X, Kang Y, Liu C, Zhou Y, Wu X, et al. Angiotensin-converting enzyme insertion/deletion polymorphism associated with acute respiratory distress syndrome among caucasians. J Int Med Res. 2010;38(2):415-22. [DOI:10.1177/147323001003800204] [PMID]
28. Pati A, Mahto H, Padhi S, Panda AK. ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population. Clin Chim Acta. 2020;510:455-8. [DOI:10.1016/j.cca.2020.08.008] [PMID] [PMCID]
29. Oscanoa TJ, Vidal X, Coto E, Romero-Ortuno R. ACE gene I/D polymorphism and severity of SARS-CoV-2 infection in hospitalized patients: A meta-analysis. Arterial Hypertension. 2021;25(3):112-8. [DOI:10.5603/AH.a2021.0018]